Skip to content

Does a Patient Education Video Augment Pelvic Floor Physical Therapy Compliance?

Does a Patient Education Video Augment Pelvic Floor Physical Therapy Compliance?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02875977
Enrollment
200
Registered
2016-08-23
Start date
2016-08-03
Completion date
2017-11-15
Last updated
2019-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient Compliance, Pelvic Floor Disorders

Brief summary

The investigators intend to measure compliance with attending pelvic floor physical therapy (PFPT) in a Urogynecology population by randomizing patients to either viewing a four minute educational video or reading a handout explaining the therapy.

Detailed description

Patients who have been interviewed, examined, and a plan has been made by the treating physicians in the Female Pelvic Medicine & Reconstructive Surgery practice will be invited to participate at the end of the visit if the patient and physician mutually agree that PFPT is the treatment modality to pursue. If she agrees to participate, she will be consented and randomized. If she is randomized to standard counseling, she will be given the standard handout to read. If she is randomized to the intervention, she will receive the standard handout and view the 4-minute educational video on an iPad. At the conclusion of the counseling, patients will be asked if they have any additional questions, and these will be recorded and answered. The patient will also fill out a visual analog scale about how informed she feels regarding PFPT.

Interventions

OTHEREducational video

A 4-minute educational video describing PFPT

A 2-page educational handout describing PFPT

Sponsors

Elizabeth Mueller
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Masking description

No masking is used in this study

Intervention model description

Participants are randomized to standard counseling for pelvic floor physical therapy (PFPT) or to an experimental counseling group that comprises both standard counseling and a 4-minute PFPT educational video using a 1:1 allocation

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who have prescribed PFPT by a treating physician in the Female Pelvic Medicine & Reconstructive Surgery practice

Exclusion criteria

* Patients ≤ 18 years old

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Completed PT Visits3 monthsThe number of patients who completed at least half of their recommended PFPT visits is compared between those assigned to enhanced counseling versus standard counseling

Secondary

MeasureTime frameDescription
Initiation of PFPT3 monthsThe number of patients who initiated PFPT is compared between those assigned to enhanced counseling versus standard counseling
PFPT Discharge3 monthsThe number of patients who discharged from PFPT is compared between those assigned to enhanced counseling versus standard counseling
Days to Initiation of PFPT3 monthsThe number of days from referral to PFPT to the first PFPT visit is compared between those assigned to enhanced counseling versus standard counseling
Change in Urogenital Distress From Baseline to 3 Months3 monthsPatients complete the Urinary Distress Inventory 6 (UDI-6) prior to beginning PFPT therapy and following PFPT therapy. The change in UDI-6 from baseline to 3 months following therapy is compared between those assigned to enhanced counseling versus standard counseling. The UDI-6 is an assessment of urogenital distress with a score range from 0 to 100, where higher scores indicate greater disability.

Countries

United States

Participant flow

Recruitment details

Patients were recruited from August 2016 through March 2017 (7 months) from a tertiary care female pelvic medicine and reconstructive surgery practice.

Participants by arm

ArmCount
Experimental Counseling
Patients randomized to this arm receive experimental counseling on the importance of attending PFPT appointments. This includes the standard 2-page educational handout and a 4-minute educational video.
100
Standard Counseling
Patients randomized to this arm receive standard counseling on the importance of attending PFPT appointments. This includes the standard 2-page educational handout.
100
Total200

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up4229

Baseline characteristics

CharacteristicStandard CounselingTotalExperimental Counseling
Age, Continuous56.77 years
STANDARD_DEVIATION 17
57.05 years
STANDARD_DEVIATION 16.52
57.32 years
STANDARD_DEVIATION 16.12
Body Mass Index29.94 kg/m^2
STANDARD_DEVIATION 6.74
31.21 kg/m^2
STANDARD_DEVIATION 7.62
32.48 kg/m^2
STANDARD_DEVIATION 8.24
Ethnicity (NIH/OMB)
Hispanic or Latino
24 Participants48 Participants24 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
75 Participants151 Participants76 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants0 Participants
Primary Language
English
94 Participants189 Participants95 Participants
Primary Language
Spanish
6 Participants11 Participants5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
3 Participants4 Participants1 Participants
Race (NIH/OMB)
Black or African American
13 Participants28 Participants15 Participants
Race (NIH/OMB)
More than one race
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
6 Participants8 Participants2 Participants
Race (NIH/OMB)
White
78 Participants159 Participants81 Participants
Region of Enrollment
United States
100 participants200 participants100 participants
Sex: Female, Male
Female
100 Participants200 Participants100 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
Urogynecologic diagnosis
Defecatory dysfunction
6 Participants12 Participants6 Participants
Urogynecologic diagnosis
Mixed Urinary Incontinence (MUI)
21 Participants55 Participants34 Participants
Urogynecologic diagnosis
Myofascial Pain
36 Participants76 Participants40 Participants
Urogynecologic diagnosis
Other Urogynecologic Diagnosis
2 Participants4 Participants2 Participants
Urogynecologic diagnosis
Pelvic Organ Prolapse (POP)
12 Participants22 Participants10 Participants
Urogynecologic diagnosis
Stress Urinary Incontinence (SUI)
25 Participants34 Participants9 Participants
Urogynecologic diagnosis
Urgency-frequency syndrome
20 Participants47 Participants27 Participants
Urogynecologic diagnosis
Urgency Urinary Incontinence (UUI)
24 Participants49 Participants25 Participants
Urogynecologic diagnosis
Weak Pelvic Floor
14 Participants22 Participants8 Participants
Vaginal Parity2 Pregnancies to a viable gestational age2 Pregnancies to a viable gestational age2 Pregnancies to a viable gestational age

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1000 / 100
other
Total, other adverse events
0 / 1000 / 100
serious
Total, serious adverse events
0 / 1000 / 100

Outcome results

Primary

Number of Participants With Completed PT Visits

The number of patients who completed at least half of their recommended PFPT visits is compared between those assigned to enhanced counseling versus standard counseling

Time frame: 3 months

Population: This analysis comprises only the participants who were randomized and had follow-up PFPT completion information available

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Experimental CounselingNumber of Participants With Completed PT VisitsCompleted half of the recommended visits47 Participants
Experimental CounselingNumber of Participants With Completed PT VisitsDid not complete half of the recommended visits11 Participants
Standard CounselingNumber of Participants With Completed PT VisitsCompleted half of the recommended visits50 Participants
Standard CounselingNumber of Participants With Completed PT VisitsDid not complete half of the recommended visits21 Participants
Comparison: The null hypothesis is that there is no difference in the odds of completing half of the recommended PFPT visits between those assigned to standard versus experimental counselingp-value: 0.1795% CI: [0.782, 4.119]Regression, Logistic
Secondary

Change in Urogenital Distress From Baseline to 3 Months

Patients complete the Urinary Distress Inventory 6 (UDI-6) prior to beginning PFPT therapy and following PFPT therapy. The change in UDI-6 from baseline to 3 months following therapy is compared between those assigned to enhanced counseling versus standard counseling. The UDI-6 is an assessment of urogenital distress with a score range from 0 to 100, where higher scores indicate greater disability.

Time frame: 3 months

Population: This analysis comprises only the participants who were randomized and had pre-PFPT and post-PFPT UDI-6 scores available

ArmMeasureValue (MEAN)Dispersion
Experimental CounselingChange in Urogenital Distress From Baseline to 3 Months-12.04 units on a scaleStandard Deviation 21.29
Standard CounselingChange in Urogenital Distress From Baseline to 3 Months-16.49 units on a scaleStandard Deviation 25.46
Comparison: The null hypothesis is that there is no difference in the change from pre-PFPT to post-PFPT UDI-6 scores between those assigned to standard versus experimental counselingp-value: 0.595% CI: [-17.6149, 8.7028]t-test, 2 sided
Secondary

Days to Initiation of PFPT

The number of days from referral to PFPT to the first PFPT visit is compared between those assigned to enhanced counseling versus standard counseling

Time frame: 3 months

Population: This analysis comprises only the participants who were randomized and initiated PFPT

ArmMeasureValue (MEDIAN)
Experimental CounselingDays to Initiation of PFPT15 Days
Standard CounselingDays to Initiation of PFPT19 Days
Comparison: Among those who initiated PFPT therapy, the null hypothesis is that there is no difference in the number of days to initiating PFPT therapy between those assigned to standard versus experimental counselingp-value: 0.16Wilcoxon (Mann-Whitney)
Secondary

Initiation of PFPT

The number of patients who initiated PFPT is compared between those assigned to enhanced counseling versus standard counseling

Time frame: 3 months

Population: This analysis comprises all participants who were randomized

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Experimental CounselingInitiation of PFPTInitiated PFPT58 Participants
Experimental CounselingInitiation of PFPTDid not initiate PFPT42 Participants
Standard CounselingInitiation of PFPTInitiated PFPT71 Participants
Standard CounselingInitiation of PFPTDid not initiate PFPT29 Participants
Comparison: The null hypothesis is that there is no difference in the odds of initiating PFPT between those assigned to standard versus experimental counselingp-value: 0.05695% CI: [0.314, 1.014]Regression, Logistic
Secondary

PFPT Discharge

The number of patients who discharged from PFPT is compared between those assigned to enhanced counseling versus standard counseling

Time frame: 3 months

Population: This analysis comprises only the participants who were randomized and had follow-up PFPT completion information available

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Experimental CounselingPFPT DischargeDischarged from PFPT27 Participants
Experimental CounselingPFPT DischargeNot discharged from PFPT29 Participants
Experimental CounselingPFPT DischargePFPT discharge status unknown2 Participants
Standard CounselingPFPT DischargeDischarged from PFPT33 Participants
Standard CounselingPFPT DischargeNot discharged from PFPT37 Participants
Standard CounselingPFPT DischargePFPT discharge status unknown1 Participants
Comparison: The null hypothesis is that there is no difference in the odds of discharge from PFPT between those assigned to standard versus experimental counselingp-value: 0.995% CI: [0.517, 2.11]Regression, Logistic

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026